Procter & Gamble beats on earnings, warns of $1 billion tariff hit

Procter & Gamble (PG) reported stronger-than-expected fiscal Q4 results, with net sales of $20.9 billion and adjusted EPS of $1.48, leading to a slight premarket share increase. Despite the beat, the company issued a cautious outlook for the new fiscal year, forecasting a $1 billion profit impact from tariffs and providing mixed EPS guidance, with the lower end below analyst expectations, while organic sales growth in several key segments lagged estimates. Additionally, P&G announced that COO Shailesh Jejurikar will succeed CEO Jon Moeller on January 1, 2026.

Analysis

Procter & Gamble (PG) presented a mixed operational picture, with fiscal fourth-quarter results surpassing analyst expectations while forward guidance signals significant headwinds. The company reported a 2% year-over-year increase in net sales to $20.9 billion and a 6% rise in adjusted EPS to $1.48, beating consensus estimates. However, this performance is overshadowed by a cautious outlook for the new fiscal year, which includes a projected $1 billion negative profit impact from tariffs. Consequently, the full-year EPS guidance of $6.83 to $7.09 has a midpoint below the $6.99 analyst consensus, and the full-year organic sales growth forecast of 0% to +4% reflects considerable uncertainty. A deeper look into the quarterly results reveals underlying weakness, as all key segments—including Beauty, Grooming, Healthcare, and Fabric Care—missed their individual organic growth estimates, indicating that the headline beat may mask broad-based softness. On the governance front, the announcement of COO Shailesh Jejurikar as the successor to CEO Jon Moeller, effective January 2026, is viewed by analysts like JPMorgan as a natural and stable transition, mitigating potential leadership continuity risk.

Key Decisions for Investors

• Investors should re-evaluate Procter & Gamble's valuation in light of the cautious full-year guidance, which incorporates a significant $1 billion profit headwind from tariffs and an EPS range with a midpoint below consensus.
• It is critical to monitor the underlying performance of individual business segments, as the across-the-board miss on organic growth estimates for categories like Grooming and Healthcare suggests broad-based weakness not apparent from the headline growth figure.
• While the planned CEO succession is viewed as a stabilizing factor, investors should watch for any shifts in strategy under incoming CEO Shailesh Jejurikar, particularly regarding plans to navigate the tariff environment and reinvigorate growth in underperforming divisions.